ArticleBMC pregnancy and childbirth2026
Restricted cubic spline analysis of the association between the third-trimester triglyceride-glucose index and neonatal birthweight in pregnant women with gestational diabetes mellitus: a multicenter cohort study.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe triglyceride-glucose (TyG) index, a surrogate indicator of insulin resistance, has been linked to adverse pregnancy outcomes. However, evidence among women with gestational diabetes mellitus (GDM) remains limited, especially concerning the relationship between the third-trimester TyG index and the risk of delivering a large for gestational age (LGA) infant. This study aimed to investigate this association and assess whether pre-pregnancy body mass index (BMI) modifies the relationship.
methodsThis retrospective multicenter cohort study included women with GDM who delivered singleton live births at four tertiary hospitals in Wuhan, China, between January 2022 and December 2023. Eligible participants had available third-trimester fasting triglyceride and fasting plasma glucose measurements for TyG index calculation. Multivariable logistic regression models were used to estimate odds ratios for LGA risk per 1-unit increase in the TyG index. Restricted cubic spline (RCS) analyses were performed to evaluate potential nonlinear associations, while stratified analyses examined differences across pre-pregnancy BMI categories. Crude LGA rates were calculated across TyG quartiles to illustrate absolute risk differences.
resultsAmong 2,754 women with GDM, 283 (10.28%) delivered LGA infants. Each 1-unit increase in the third-trimester TyG index was associated with a significantly greater risk of LGA (adjusted OR 1.80, 95% CI 1.44-2.27). RCS analysis suggested a modest nonlinear association (P for nonlinearity = 0.046). The crude incidence of LGA increased from 7.6% in the lowest TyG quartile (Q1) to 16.3% in the highest quartile (Q4), corresponding to an absolute risk difference of 8.7 percentage points. The associations remained directionally consistent across BMI subgroups, with no significant interaction observed between TyG index and pre-pregnancy BMI (P for interaction > 0.05).
conclusionsAn elevated third-trimester TyG index was independently associated with a higher risk of LGA in women with GDM. Although a potential nonlinear relationship was identified, the evidence supporting nonlinearity was limited. These findings support a statistical association rather than established clinical applicability. Further prospective studies are required to determine whether the TyG index can contribute to risk stratification or clinically meaningful risk assessment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.